WITHDRAWN: Comparative effectiveness of extended release naltrexone and sublingual buprenorphine for treatment of opioid use disorder among Medicaid patients

Rachael K. Ross, Edward V. Nunes, Mark Olfson, Matisyahu Shulman, Noa Krawczyk, Elizabeth A. Stuart, Kara E. Rudolph
doi: https://doi.org/10.1101/2024.01.24.24301555

Article usage

Article usage: January 2024 to August 2025

AbstractFullPdf
Jan 2024158643
Feb 2024189744
Mar 2024136943
Apr 2024309753
May 2024111828
Jun 202448414
Jul 202447424
Aug 202444215
Sep 202443411
Oct 20242074025
Nov 20245791824
Dec 2024470244
Jan 2025257020
Feb 2025251030
Mar 2025269035
Apr 2025225038
May 2025199019
Jun 2025206023
Jul 2025213039
Aug 2025502
Back to top
Posted April 01, 2024.
Download PDF

Supplementary Material

Email
WITHDRAWN: Comparative effectiveness of extended release naltrexone and sublingual buprenorphine for treatment of opioid use disorder among Medicaid patients
Rachael K. Ross, Edward V. Nunes, Mark Olfson, Matisyahu Shulman, Noa Krawczyk, Elizabeth A. Stuart, Kara E. Rudolph
medRxiv 2024.01.24.24301555; doi: https://doi.org/10.1101/2024.01.24.24301555
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area